Sartorius Stedim Biotech Stock (OTC: SDMHF)

Latest news for Sartorius Stedim Biotech (OTC:SDMHF) Stock

Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.

News

Guidance

Contracts

Management

Global

SDMHF

Sartorius, BD Diagnostics Announce Collaboration

SARTORIUS STEDIM BIOTECH by Sartorius Stedim Biotech

Sartorius Stedim Biotech SA

Sartorius Stedim Biotech S.A. (SDMHF) Q4 2023 Earnings Call Transcript

Sartorius Stedim Biotech S.A. goes ex dividend tomorrow

Sartorius AG: It's A Good Long-Term Play, But 'Wait And See' Approach Is More Conservative Now

RGA Investment Advisors - Sartorius: Purity In The Pure Play Of Bioprocessing

Sartorius Stedim Biotech S.A. GAAP EPS of €1.08, revenue of €1.37B

Sartorius Stedim Biotech S.A. 2024 Q2 - Results - Earnings Call Presentation

Sartorius Stedim Biotech S.A. (SDMHF) H1 2024 Earnings Call Transcript

American Century International Growth Fund Q2 2024 Commentary

Sartorius Stedim Biotech S.A. reports Q3 results

Sartorius Stedim Biotech S.A. (SDMHF) Q3 2024 Earnings Call Transcript

AEMB

AHYB

ARKAF

ASML

EADSF

EDNMF

ESGA

ESGY

FUSI

KORP

KYCCF

NSRGF

PALL

QCON

QGRO

QINT

QPFF

SARTF

SBGSF

SDSI

SOAGY

SRTOY

SSSGY

SUVPF

TAXF

VALQ

Sartorius Stedim Biotech

Upgrades

Downgrades

Initiation

Intraday Update

Analyst Ratings

AADI

ALIZY

ALZN

AMZN

BABA

BCYP

CANO

CHTR

COUP

COVTY

CRCT

CSSE

DLTR

EGLX

ENPH

FIVN

GNLN

GOOGL

HESM

JOAN

LTHM

NOVA

PETS

PLAN

PLBY

PLUG

QCOM

RCOR

SAVE

SEDG

SIVB

SLGN

SNAP

SPRO

TELDF

ULCC

UPWK

VLTA

WLDPF

XLRN

Benzinga's Top Ratings Upgrades, Downgrades For October 1, 2021

Societe Generale   downgrades Sartorius Stedim Biotech (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SDMHF#OTC">SDMHF</a>) from Buy to Hold.

Societe Generale Downgrades Sartorius Stedim Biotech to Hold

Sartorius Stedim Biotech (OTC: <a class="ticker" href="/stock/sdmhf#OTC">SDMHF</a>) and BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: <a class="ticker" href="/stock/bdx#NYSE">BDX</a>) today announced a collaboration to develop, manufacture and market various&nbsp; ready-to-use, prefilled media products for microbiological applications in pharmaceutical, biotech and research laboratories.

"Through our agreement with BD, we have created an excellent collaboration. BD is known worldwide for its expertise in manufacturing and filling of microbial media. BD's expertise combined with Sartorius Stedim Biotech's know-how in polymeric technologies and applications will help us further extend our expert capabilities in the field of microbiological monitoring," says Dominique Baly, member of the Sartorius Group Executive Committee.

Based on its many years of expertise in the development of membranes, SSB offers high-quality, single-use filter products for concentration of microbial contaminants in the lab. As part of this strategic collaboration, BD will fill special SSB single-use products with BD culture media and supply these to SSB as prepackaged products.&nbsp; In addition, the companies are exploring options of extending their existing business relationship by pursuing further innovative solutions in
    
    <a href="http://www.benzinga.com/pressreleases/13/10/n3994333/sartorius-stedim-biotech-and-bd-diagnostics-strengthen-cooperation-in-t">See full press release</a>

Comments

Sartorius Stedim Biotech

News

Latest news for Sartorius Stedim Biotech (OTC:SDMHF) Stock

Friday, October 01, 2021

Wednesday, October 16, 2013

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga